Genmed appoints Nicky Carless as national sales manager
April 2, 2019 – Genmed, a specialist provider of vendor neutral managed services to the NHS, today announces the appointment...
user
Gateshead Health extends use of BridgeHead’s HealthStore®
BridgeHead’s Independent Clinical Archive will now house all medical images across the TrustASHTEAD, UK – 2 April 2019 – As...
Jaguar Health Subsidiary Napo Pharmaceuticals Issues Further Regulatory Update Regarding Potential Follow-on Indication for Mytesi
SAN FRANSISCO, CA / ACCESSWIRE / April 2, 2019 / Napo Pharmaceuticals, Inc. (Napo), a human health company developing and...
Dr. Sarah Fakih joins MorphoSys as Head of Corporate Communications and Investor Relations
PLANEGG/MUNICH GERMANY / ACCESSWIRE / April 1, 2019 / Dr. Sarah Fakih joined MorphoSys AG (FSE: MOR; Prime Standard Segment,...
Kadmon Announces Appointment of Arthur Kirsch to Board of Directors
NEW YORK, NY / ACCESSWIRE / April 1, 2019 / Kadmon Holdings, Inc. (NYSE: KDMN) today announced that Arthur Kirsch...
ReShape Lifesciences Announces Fourth Quarter and Full Year 2018 Financial Results
SAN CLEMENTE, CA / ACCESSWIRE / April 1, 2019 / ReShape Lifesciences Inc. (NASDAQ: RSLS), a developer of minimally invasive...
NHS doctors train using virtual reality to improve care for people with diabetes
The NHS England diabetes team has partnered with Oxford Medical Simulation to train doctors using virtual reality. Doctors can now...
Experion Completes First Shipment to the Province of Saskatchewan
CALGARY, AB / ACCESSWIRE / April 1, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (OTC...
Positive Pilot Phase 3 Data Position VistaGen’s PH94B Neuroactive Nasal Spray for Pivotal Phase 3 Development as a Novel, As-Needed Treatment for Social Anxiety Disorder
PH94B has potential to be the First FDA-Approved PRN Treatment for Social Anxiety Disorder New Findings Presented at the 2019...
ReShape Lifesciences Implants First Patient in ENDURE II Trial to Support CE Marking of ReShape Vest
SAN CLEMENTE, CA / ACCESSWIRE / April 1, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive...
Savara Initiates Phase 2a Clinical Study of Molgradex for the Treatment of NTM Lung Infection in People Living with Cystic Fibrosis
AUSTIN, TX / ACCESSWIRE / April 1, 2019 / Savara Inc. (NASDAQ: SVRA), an orphan lung disease company, today announced...
Parallax Health Sciences Reports 2018 Operating and Financial Results Records Net Income of $16.3 Million
Initiates $6 Million Equity Financing Company Now Positioned for Growth through Execution on Multi-faceted Strategy SANTA MONICA, CALIF / ACCESSWIRE...
EVOTEC AG COMPLETES CONVERSION INTO EVOTEC SE
HAMBURG, GERMANY / ACCESSWIRE / April 1, 2019 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today...
Completion of Name Change and Consolidation
VANCOUVER, BC / ACCESSWIRE / March 28, 2019 / Canland Health Corp. (formerly, 1155176 B.C. LTD.) (the "Company") is pleased...
ENDRA Life Sciences Reports Initial Findings on First Human TAEUS Feasibility Study of Liver Fat
ANN ARBOR, MI / ACCESSWIRE / March 29, 2019 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ: NDRA), a developer of...
Vycor Medical Reports Financial Results for the Year Ended December 31st, 2018
BOCA RATON, FL / ACCESSWIRE / March 29, 2018 / Vycor Medical, Inc. (Vycor) (OTCQB: VYCO), a provider of innovative...
U.S. FDA Acknowledges Receipt of Intellipharmaceutics’ Resubmission of Oxycodone ER New Drug Application, Deems it a Complete Response, and Designates August 28, 2019 as Goal Date for Review
TORONTO, ON / ACCESSWIRE / March 29, 2019 / Intellipharmaceutics International Inc. (OTCQB: IPCIF and TSX: IPCI) ("Intellipharmaceutics" or the...
ReShape Lifesciences Announces $2 Million Convertible Note Financing
SAN CLEMENTE, CA / ACCESSWIRE / March 29, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive...
Milestone Scientific Schedules 2018 Year-End Earnings Conference Call
LIVINGSTON, NJ / ACCESSWIRE / March 29, 2019 / Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized...
Nexien BioPharma to Present at The MicroCap Conference Spring Investor Summit on Tuesday, April 2nd
DENVER, CO / ACCESSWIRE / March 28, 2019 / Nexien BioPharma, Inc. ("Nexien" or the "Company") (OTCQB: NXEN), a next...